This book, besides reviewing basic and clinical aspects of BehÃ{u00A7}et's disease, covers the latest findings, including genetic studies and treatment with biologics for the disease. Although the cause of BehÃ{u00A7}et's disease is still unknown, it is well known that genetic factors, such as HLA-B51, are involved in its development. Recently, novel susceptibility loci including IL10, IL23R-IL12RB2, and endoplasmic reticulum aminopeptidase 1 have been identified, providing new insights into the pathogenesis of the disease. In addition to basic research, the beneficial efficacy of anti-TNF-alpha monoclonal antibodies has also been suggested for not only uveitis associated with the disease but also other subtypes of the disease such as entero-, vasculo-, and neuro- BehÃ{u00A7}et's disease. BehÃ{u00A7}et's Disease:Â{u01B2}om Genetics to Therapies Â{u0CAF}vides essential information both for basic researchers working in the fields of immunology, inflammation, and genetics, and for clinical physicians who are interested in BehÃ{u00A7}et's disease, such as ophthalmologists, rheumatologists, dermatologists, gastroenterologists, neurologists, and vascular surgeons.